- $71.26m
- $69.24m
- $18.41m
Annual income statement for INLIF, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.15 | 6.65 | 12.6 | 15.8 | 18.4 |
| Cost of Revenue | |||||
| Gross Profit | 2 | 2.29 | 4.16 | 4.55 | 4.29 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 5.81 | 6 | 11.2 | 14.5 | 24.2 |
| Operating Profit | 0.349 | 0.65 | 1.39 | 1.29 | -5.82 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.036 | 0.537 | 1.36 | 1.62 | -5.45 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.037 | 0.538 | 1.35 | 1.61 | -5.45 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.037 | 0.538 | 1.35 | 1.61 | -5.45 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.037 | 0.538 | 1.35 | 1.61 | -5.45 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.003 | 0.037 | 0.093 | 0.129 | -0.329 |